Related Experiment Video

Updated: Aug 9, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Impact of the quebec school-based hepatitis B immunization program and potential benefit of the addition of an infant

Vladimir Gîlca1, Bernard Duval, Nicole Boulianne

  • 1Institut National de Santé Publique du Québec, Canada. vladimir.gilca@ssss.gouv.qc.ca

The Pediatric Infectious Disease Journal
|March 29, 2006
PubMed

Insights

A decade-long school hepatitis B vaccination program proved highly effective. Adding infant immunizations could further reduce hepatitis B cases and improve public health outcomes.

Area of Science:

  • Public Health
  • Immunology
  • Epidemiology

Background:

  • Hepatitis B virus (HBV) infection poses a significant global health burden.
  • School-based vaccination programs aim to control HBV transmission.
  • Assessing long-term program effectiveness is crucial for public health policy.

Purpose of the Study:

  • To evaluate the 10-year impact of a school-based hepatitis B immunization program.
  • To identify factors contributing to vaccine failure and assess risk factors for breakthrough infections.
  • To estimate the potential benefit of incorporating an infant vaccination program.

Main Methods:

  • Retrospective analysis of a school-based hepatitis B immunization program data over 10 years.
  • Case-control study to identify risk factors for vaccine failure.
  • Mathematical modeling to estimate preventable cases with an infant program.

Main Results:

  • The preteen hepatitis B vaccination program demonstrated high effectiveness over a decade.
  • Identified specific risk factors associated with vaccine failure.
  • Projected significant additional benefits from the introduction of an infant immunization program.

Conclusions:

  • The established school-based hepatitis B vaccination program is a successful public health intervention.
  • Supplementing the current program with infant hepatitis B vaccination is recommended for enhanced disease prevention.
  • Further research into optimizing vaccination strategies is warranted.

More Related Videos

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment09:27

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment

Published on: May 6, 2020

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...